The kinetics of aluminium absorption were determined in patients with duodenal ulcer and in 2 normal males after taking the antacid Tisacid (Biogal, Hungary). A peak serum aluminium of 54.5 μg/l was reached at 30 min, returning to the initial value of 6.8 μg/l at 3 h after the oral intake. Urinary but not serum aluminium increased in parallel to the amount of drug taken. The serum AI values are considerably influenced by the time of sampling. Owing to the rapid absorption and excretion of aluminium, there appears to be no danger of aluminium deposits in the tissues or of neurological alterations, provided renal function is normal.
Introduction
Widely varying serum aluminium values are observed in ulcer patients regularly taking the aluminium-containing antacid, "Tisacid" (Biogal, Hungary). Preanalytical error was considered s a possible explanation. Since no detailed data are available on the absorption of antacids in man (1-3), we carried out an experiment on ourselves, speculating that knowledge of the time course of absorption and of the time points of sampling might help to clarify the surprising differences in results.
Patients and Method
Serum and urinary concentratioris of aluminium were determined in six patients with duodenal ulcer after treatment with Tisacid (formula: Α1 2 Μ&(ΟΗ)ι 2 ΟΟ 3 · tH 2 O). It is supplied in tablets, each containing 105.06 mg magnesium, 58.1 mg aluminium and vehicles. All patients took 4X2 tablets in 0.11 of tap water per day. Blood samples were generally drawn on an empty stomach prior to, and occasionally after, the administration of Tisacid.
Two experiments were conducted on the authqrs themselves. In the first, they took 18 tablets within 37h; in the first 8 h, 2 tablets every 2h and then, following a break of 16h, 5X2 tablets at intervals of 2 h. The serum and urinary concentration of aluminium were determined at 6, 30 and 60 h after administration of the first tablets. In the second experiment blood was collected in a Braun cannula at 15, 30, 45 and 60 min, and then at 2, 3 and 4h after the ingestion of 4 tablets of Tisacid, urine being collected for 24 h. The aluminium concentration in l mol/1 HC1 extfacts from stools was determined on days prior to the experiment and after the taking An oral toierance lest with 50 g glucose was performed after an aluminium loading study. The serum aluminium concentration of the glucose samples did not exceed 10 μg/l.
The aluminium content was determined using a Varian SpektrAA.20 atomic absorption spectrometer equipped with a GTA-96 graphite tube atomizer (4^-6). The results of the determinations are given in μg/l (factor: 0.037 X μg/l = μπιοΐ/ΐ). Aluminium samples were collected in polypropylene vessels (BCL. Lewes, Sussex, UK), which were washed with diluted nitric acid (volume fraction 0.1) and rinsed with distilled deionized water before use to minimize aluminium contamination.
Statistical analyses
A reference aluminium solutipn ("1000 ppm u , = l g/l, Sigma, USA) was used to prepare fresh Standard aluminium Solutions daily. The calibration curve was linear with a correlation coefficient (r 2 ) of 0.98. The limit of detection was 6 μ §/1. The analytical method was validated by addition of a Standard solution of AI (10 to 100 μg/l) to serum. The measured aluminium concentration was linearly related to the theoretical aluminium content, with an r 2 value of 0.98. Repeated determinations showed the coefficient of Variation to be lower thari 5% (n = 7). There was no significant Statistical difference between the data obtained from the direct and the Standard addition methods (t test for paired observations gave P > 0.05). Sensitivity, s the quantity needed to give 1% absorption, was found to be 0.8 μ §/1, and for l : 5 diluted serum, 3.0 μg/l. Data are presented s means ± SD: the serum aluminium values of antacid-treated patients were 8.9 ± 2.1 μg/l, in the experiments on ourselves 7.7 ± 1.5 μg/l aluminium.
Rcsults
Figure l presents the aluminium values for serum and urine observed in one of the 6 patients with duodenal ulcer in the course of Tisacid treatment. At serum values under 10.0 μg/l, accepted s normal, the excretion of aluminium did not exceed the permissible concentration of 30.0 μg/l. The serum aluminium concentration of the other 5 Tisacid-treated patients, calculated from 34 serum samples, was 8.9 ± 2.1 μg/l. However, the threeday value for serum aluminium was extremely and inexplicably high. It was this exceptionally high value of 54.5 μg/l that led us to conduct experiments on ourselves under strictly controlled conditions. Figure 3 shows the results of the second examination, s well s presenting the dynamics of glucose absorption. As in the case of glucose, the absorption of aluminium reaches its peak (39 μg/l) at 30 min, and after 4 h it reverts to the initial value (6.8 μg/l; P < 0.05) (1). In a separate experiment about 90% of the aluminium taken in the 4 tablets of Tisacid was recovered in the stools collected over a period of 24 h. Thus, of the orally administered aluminium, s little s 10% was absorbed. 
Discussion
Our investigations explain why no elevated serum aluminium values have been observed by other workers (see fig. 2 ). It m y be supposed that the exceptionally high value recorded on day 3 (shown in fig. 1 ) reflects the aluminium concentration of the blood .sample drawn at 30 min after the taking of Tisacid (see fig. 3 ), in contrast to the aluminium concentrations of the other blood samples obtained eartier or later.
The data ori the kineties of aluminium absorption call attention to the importance of v the time ipoint of ,sam-pling, and provide an explanation for the occasionally extremely conflicting results. The occurrence of dialysis dementia in renal patients who havc accumulated large amounts ofaluminium from the water used for dialysis is well documented (7) . However, with normal renal function, äs in our case, the limited but rapid absorption and excretion may perhaps explain why the treatment of ulcer patients with aluminium-containing Tisacid is not accompanied with neurological signs and Symptoms (8) .
